P A Kyrle - JoVE Visualize

Showing results (61-70 of 104) with videos related to

Pageof 11

Sort By:

European Journal of Haematology|December 12, 2001

Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutationC Rintelen, I Pabinger, P Bettelheim, et al.

The Journal of Pediatrics|February 5, 1999

Clinical significance of lupus anticoagulants in childrenC Male, K Lechner, S Eichinger, et al.

Journal of Thrombosis and Haemostasis : JTH|December 20, 2005

The post-thrombotic syndrome: risk factors and impact on the course of thrombotic diseaseM Stain, V Schönauer, E Minar, et al.

Blut|November 1, 1990

Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: activation of blood coagulation, fibrinolysis and unspecific proteolysisW Speiser, I Pabinger-Fasching, P A Kyrle, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991

Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptorJ Ware, J A Dent, H Azuma, et al.

Clinical Cardiology|March 1, 1991

Pacing-induced myocardial ischemia does not affect the endothelial release of coagulant and fibrinolytic factors into the coronary circulationH D Gössinger, W Speiser, P Siostrzonek, et al.

British Journal of Haematology|May 1, 1996

Effects of desmopressin on circulating P-selectinB Jilma, H G Eichler, B Vondrovec, et al.

Clinical Pharmacology and Therapeutics|October 1, 1995

Effects of cisplatin on urinary thromboxane B2 excretionB Blöchl-Daum, H Pehamberger, C Kurz, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 1995

Role of nitric oxide in hemostatic system activation in vivo in humansK Krejcy, L Schmetterer, J Kastner, et al.

Thrombosis and Haemostasis|March 1, 1995

Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in manM Wolzt, A Weltermann, M Nieszpaur-Los, et al.

Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:

Pageof 11

European Journal of Haematology|December 12, 2001

Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutationC Rintelen, I Pabinger, P Bettelheim, et al.

The Journal of Pediatrics|February 5, 1999

Clinical significance of lupus anticoagulants in childrenC Male, K Lechner, S Eichinger, et al.

Journal of Thrombosis and Haemostasis : JTH|December 20, 2005

The post-thrombotic syndrome: risk factors and impact on the course of thrombotic diseaseM Stain, V Schönauer, E Minar, et al.

Blut|November 1, 1990

Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: activation of blood coagulation, fibrinolysis and unspecific proteolysisW Speiser, I Pabinger-Fasching, P A Kyrle, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991

Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptorJ Ware, J A Dent, H Azuma, et al.

Clinical Cardiology|March 1, 1991

Pacing-induced myocardial ischemia does not affect the endothelial release of coagulant and fibrinolytic factors into the coronary circulationH D Gössinger, W Speiser, P Siostrzonek, et al.

British Journal of Haematology|May 1, 1996

Effects of desmopressin on circulating P-selectinB Jilma, H G Eichler, B Vondrovec, et al.

Clinical Pharmacology and Therapeutics|October 1, 1995

Effects of cisplatin on urinary thromboxane B2 excretionB Blöchl-Daum, H Pehamberger, C Kurz, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 1995

Role of nitric oxide in hemostatic system activation in vivo in humansK Krejcy, L Schmetterer, J Kastner, et al.

Thrombosis and Haemostasis|March 1, 1995

Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in manM Wolzt, A Weltermann, M Nieszpaur-Los, et al.

Pageof 11